Income Taxes - Schedule of Reconciliations of the Differences between the Income Tax Expenses (Details) ¥ in Thousands, $ in Thousands |
6 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2024
CNY (¥)
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
CNY (¥)
|
Mar. 31, 2024
CNY (¥)
|
Mar. 31, 2024
USD ($)
|
Mar. 31, 2023
CNY (¥)
|
Mar. 31, 2022
CNY (¥)
|
|||
| Schedule of Reconciliations of the Differences between the Income Tax Expenses [Abstract] | |||||||||
| Loss before income taxes | ¥ (69,875) | ¥ (106,805) | ¥ (134,812) | ||||||
| Income tax computed at respective applicable tax rates | (17,469) | (26,701) | (33,702) | ||||||
| Effect of different tax jurisdiction | 6,976 | 12,323 | 2,341 | ||||||
| Super deduction for research and development expenses | [1] | (547) | (456) | (1,881) | |||||
| Non-deductible expenses | 115 | 728 | 97 | ||||||
| Change in valuation allowance | 11,852 | 15,017 | 34,716 | ||||||
| Income tax benefit | ¥ 445 | $ 63 | ¥ 482 | ¥ 927 | $ 128 | ¥ 911 | ¥ 1,571 | ||
| |||||||||
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|